Biogen | Lngresos Netos





Lngresos Netos Cambio Fecha
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
ALKERMES USD 82.76M 4.34M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Bayer EUR -963M 764M 2025-09
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
United Therapeutics USD 338.7M 29.2M 2025-09
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12


Biogen Lngresos Netos - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.